HitGen Inc
SSE:688222

Watchlist Manager
HitGen Inc Logo
HitGen Inc
SSE:688222
Watchlist
Price: 12.07 CNY -7.08% Market Closed
Market Cap: 4.8B CNY
Have any thoughts about
HitGen Inc?
Write Note

HitGen Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

HitGen Inc
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
HitGen Inc
SSE:688222
Total Liabilities & Equity
ÂĄ1.7B
CAGR 3-Years
2%
CAGR 5-Years
28%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Total Liabilities & Equity
ÂĄ74.4B
CAGR 3-Years
13%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Total Liabilities & Equity
ÂĄ23B
CAGR 3-Years
11%
CAGR 5-Years
34%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Total Liabilities & Equity
ÂĄ56.1B
CAGR 3-Years
9%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Total Liabilities & Equity
ÂĄ30.4B
CAGR 3-Years
11%
CAGR 5-Years
37%
CAGR 10-Years
38%
W
WuXi XDC Cayman Inc
HKEX:2268
Total Liabilities & Equity
ÂĄ6.7B
CAGR 3-Years
155%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

HitGen Inc
Glance View

Market Cap
4.8B CNY
Industry
Life Sciences Tools & Services

HitGen, Inc. engages in the provision deoxyribonucleic acid encoded compound library (DEL) for research and development of seed and lead compounds. The company is headquartered in Chengdu, Sichuan and currently employs 508 full-time employees. The company went IPO on 2020-04-16. The firm focuses on the research and creation of deoxyribonucleic acid encoded compound library (DEL) technology, research and development of hit compounds and lead compounds. The firm mainly provides DEL screening services, DEL library customization services, chemical synthesis services and transfer of new drug research and development projects. The firm conducts its businesses within the domestic market and to overseas markets.

Intrinsic Value
7.23 CNY
Overvaluation 40%
Intrinsic Value
Price

See Also

What is HitGen Inc's Total Liabilities & Equity?
Total Liabilities & Equity
1.7B CNY

Based on the financial report for Dec 31, 2023, HitGen Inc's Total Liabilities & Equity amounts to 1.7B CNY.

What is HitGen Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
28%

Over the last year, the Total Liabilities & Equity growth was 4%. The average annual Total Liabilities & Equity growth rates for HitGen Inc have been 2% over the past three years , 28% over the past five years .

Back to Top